A Phase 3 Multicenter, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Adult Patients With Atopic Dermatitis
收藏DataCite Commons2025-10-20 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00011871/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the long-term safety and efficacy of baricitinib in participants with atopic dermatitis.Participants were enrolled in this study from the originating studies (JAHL, JAHM, JAIY) or were directly enrolled in the open-label arm.
提供机构：
Vivli
创建时间：
2025-10-17
